UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039651
Receipt number R000045226
Scientific Title A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study
Date of disclosure of the study information 2020/03/01
Last modified on 2020/02/29 22:50:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study

Acronym

A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study

Scientific Title

A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study

Scientific Title:Acronym

A Combined Thoracic Interfascial Plane Block for Postoperative Pain Relief and Quality of Recovery after Breast Cancer Surgery: A Prospective, Observational Cohort Study

Region

Japan


Condition

Condition

Patients undergoing breast cancer surgery

Classification by specialty

Breast surgery Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Chronic pain after breast cancer surgery adversely affects the patient's daily life and reduces the quality of life. As a method of preventing chronic pain after breast cancer surgery, it is adequate to relieve acute pain immediately after surgery. As a method, peripheral nerve block performed on the chest wall was reported by Blanco et al., attracting attention as a low-risk analgesic method after breast surgery. Recently, many variants of this block have been reported, and some of them have been combined to provide a broader range of analgesia.
As an evaluation of postoperative analgesia, a VAS scale or NRS scale of pain is generally used, but in recent years, an analgesic method has been evaluated from the viewpoint of the quality of recovery after the operation (Quality of Recovery). However, no effect of the combination of peripheral nerve block of the chest wall as described above on the quality of postoperative recovery, has been reported.
The primary purpose of this study is to examine the effects of a combination of chest wall peripheral nerve blocks on pain and quality of recovery after breast surgery as a prospective observational study in the acute and chronic phases (up to one year after surgery).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Visual Analog Scale (VAS) pain score 3 hours after surgery

Key secondary outcomes

Visual Analog Scale (VAS) pain score for "morning following surgery" and "maximum until the morning after surgery."
Quality of Recovery (QoR-40; questionnaire consisting of 40 items) before and three days after surgery, 1, 3, 6, and 12 months after surgery.
Patient age, height, weight, gender
Surgery time
Total fentanyl usage, total remifentanil usage
Postoperative nausea and vomiting
Frequent use of postoperative analgesics
Time to need the first rescue analgesia
Whether there are complications associated with the block (vascular puncture, pneumothorax, hematoma, nerve damage, etc.)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Female

Key inclusion criteria

Patients undergoing breast cancer surgery at Bell Land General Hospital.

Key exclusion criteria

Patients who do not agree with this study, pregnant and parturient women, allergy to local anesthetics, significant psychiatric or mental disorders, patients with chronic pain.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Toshinori
Middle name
Last name Horiuchi

Organization

Bell Land General Hospital

Division name

Department of Anesthesia

Zip code

599-8247

Address

500-3, Higashiyama, Naka-Ku, Sakai, Osaka

TEL

0745381023

Email

thoriuch@kcn.jp


Public contact

Name of contact person

1st name Toshinori
Middle name
Last name Horiuchi

Organization

Bell Land General Hospital

Division name

Department of Anesthesia

Zip code

599-8247

Address

500-3, Higashiyama, Naka-Ku, Sakai, Osaka

TEL

0722342001

Homepage URL


Email

t_horiuchi@seichokai.or.jp


Sponsor or person

Institute

Department of Anesthesia, Bell Land General Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Bell Land General Hospital Institutional Review Board

Address

500-3, Higashiyama, Naka-Ku, Sakai, Osaka

Tel

0722342001

Email

rib@seichokai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ベルランド総合病院(大阪府)


Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 01 Day

Date of IRB

2020 Year 02 Month 20 Day

Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observe the primary outcome, the Visual Analog Scale (VAS) pain score 3 hours after surgery, and the secondary outcomes, which are:
Quality of Recovery (QoR-40; questionnaire consisting of 40 items) before and three days after surgery, 1, 3, 6, and 12 months after surgery.
Visual Analog Scale (VAS) pain score for "morning following surgery" and "maximum until the morning after surgery."
Patient age, height, weight, gender
Surgery time
Total fentanyl usage, overall remifentanil usage
Postoperative nausea and vomiting
Frequent use of postoperative analgesics
Time to need the first rescue analgetic
Whether there are complications associated with the block (vascular puncture, pneumothorax, hematoma, nerve damage, etc.)


Management information

Registered date

2020 Year 02 Month 29 Day

Last modified on

2020 Year 02 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name